Patent application number | Description | Published |
20150294506 | System and Method for Augmented Reality Display of Dynamic Environment Information - A method for providing environment information to a mobile device user is presented. The method comprises receiving a request for target environment information from a mobile device, determining the pose of the mobile interface device relative to the target environment, and obtaining target environment data for one or more measurable environment parameters (e.g., radiation level). The target environment data is used to assemble augmented reality information configured for viewing in conjunction with a real-time view of the target environment captured by the mobile interface device. The target augmented reality information is then transmitted to the mobile device for display to the user. | 10-15-2015 |
20150310279 | Augmented Reality Display of Dynamic Target Object Information - A method for providing target object information to a mobile device user is presented. The method includes receiving a request for target object information from a mobile device, determining the pose of the mobile interface device relative to the target object, and obtaining target object data for one or more measurable target object parameters (e.g., surface topography). The target object data is used to assemble augmented reality information configured for viewing in conjunction with a real-time view of the target object captured by the mobile interface device. The target object augmented reality information is then transmitted to the mobile device for display to the user. | 10-29-2015 |
20150347854 | System and Method for Using Augmented Reality Display in Surface Treatment Procedures - A method for providing target object surface information to a mobile device user is presented. The method includes receiving a request for target object surface information from a mobile device, determining the pose of the mobile interface device relative to the target object, and obtaining target object surface information for one or more measurable target object surface parameters. The target object data is used to assemble augmented reality surface information configured for viewing in conjunction with a real-time view of the target object captured by the mobile interface device. The target object augmented reality surface information is then transmitted to the mobile device for display to the user. | 12-03-2015 |
20150356786 | System and Method for Augmented Reality Display of Electrical System Information - A method for providing electrical system status information to a mobile device user is presented. The method comprises receiving a request for target area electrical system status information from a mobile device, determining the pose of the mobile interface device relative to the target area, obtaining target area electrical system status information for a target electrical system at least partially disposed within the target area, and assembling AR electrical system status information for transmission to and display on the mobile interface device. The AR electrical system status information is assembled using the target area electrical system status information and is configured for viewing in conjunction with a real-time view of the target area captured by the mobile interface device. The AR electrical system status information is then transmitted to the mobile interface device. | 12-10-2015 |
Patent application number | Description | Published |
20140023720 | ENHANCED AUTOLOGOUS GROWTH FACTOR PRODUCTION AND DELIVERY SYSTEM - Systems and methods for producing enhanced blood serum with concentrated growth factors and/or prophylactically and therapeutically active proteins. An autologous blood product is obtained from a donor and then incubated into a containment device (sterile container) that includes a source of cells or tissue (for example, autologous, allogeneic, or xenographic tissue, or combinations thereof). The cells from the injected fluid (autologous blood product) interact/incubate with the source of cells or tissue inside the containment device, to produce a serum that is loaded with autologous proteins, growth factors, and cytokines. The autologous blood product may be a fluid and/or composition that includes blood, whole blood, autologous conditioned plasma, platelet-rich plasma, platelet-poor plasma, bone marrow aspirate, bone marrow concentrate and stem cells, among others, and combinations thereof. | 01-23-2014 |
20140249071 | ENHANCED ANABOLIC CYTOKINE PRODUCTION AND DELIVERY SYSTEM - Techniques and devices for removing (filtering out) unwanted/inhibitory components (for example, products, byproducts and/or cell output such as inhibitory catabolic proteins) from a composition (for example, autologous fluid or serum) containing such unwanted/inhibitory components. The devices include at least one construct designed to contain a composition (for example, autologous fluid or serum) containing inhibitory/unwanted components (products, byproducts and/or output of cells such as inhibitory catabolic proteins). The construct is provided with interior walls including specific protein capturing means designed to remove the inhibitory/unwanted component(s) (for example, specific protein(s)) from the composition. Proteins targeted for capture include, but are not limited to, catabolic cytokines such as IL-1β, IL-α, IL-6, TNFα, IFNγ and MMPS as these proteins inhibit the healing process. | 09-04-2014 |
20150209502 | TRIPLE SYRINGE AND METHODS OF MAKING PLATELET-ENRICHED PLASMA AND USE THEREOF - A triple syringe system that allows for either a larger volume of ACP, or a larger combined output of PRP (platelet rich plasma) and PPP (platelet poor plasma). The different outputs are based upon different centrifuge spin regimes. The system of the present invention produces up to 15 mL of ACP, or 3 mL of PRP plus 25 mL of PPP. The system of the present invention solves the problem of a larger volume of ACP and with a higher cellular concentration. The multi-syringe system allows for the connection of two or more additional syringes. The fractions may be extracted with the multi-syringe system of the present invention at different sequential times, or at the same time. | 07-30-2015 |
20160101132 | ENHANCED ANABOLIC CYTOKINE PRODUCTION AND DELIVERY SYSTEM - Techniques and devices for removing (filtering out) unwanted/inhibitory components (for example, products, byproducts and/or cell output such as inhibitory catabolic proteins) from a composition (for example, autologous fluid or serum) containing such unwanted/inhibitory components. The devices include at least one construct designed to contain a composition (for example, autologous fluid or serum) containing inhibitory/unwanted components (products, byproducts and/or output of cells such as inhibitory catabolic proteins). The construct is provided with interior walls including specific protein capturing means designed to remove the inhibitory/unwanted component(s) (for example, specific protein(s)) from the composition. Proteins targeted for capture include, but are not limited to, catabolic cytokines such as IL-1β, IL-α, IL-6, TNFα, IFNγ and MMPS as these proteins inhibit the healing process. | 04-14-2016 |
Patent application number | Description | Published |
20090258003 | Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof - The present invention is based on the discovery of genetic polymorphisms that are associated with coronary heart disease and in particular VT and response to drug treatment. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 10-15-2009 |
20090270332 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with venous thrombosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 10-29-2009 |
20120039864 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with coronary heart disease and in particular VT and response to drug treatment. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 02-16-2012 |
20120108651 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF - The present invention provides compositions and methods based on genetic polymorphisms that are associated with response to statin treatment (particularly for reducing the risk of venous thrombosis). For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection. | 05-03-2012 |
20120264692 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with venous thrombosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 10-18-2012 |
20130045198 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with coronary heart disease and in particular VT and response to drug treatment. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 02-21-2013 |
20130274195 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with venous thrombosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 10-17-2013 |
20140128362 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF - The present invention provides compositions and methods based on genetic polymorphisms that are associated with response to statin treatment (particularly for reducing the risk of venous thrombosis). For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection. | 05-08-2014 |
20140186333 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF - The present invention is based on the discovery of genetic polymorphisms that are associated with coronary heart disease and in particular VT and response to drug treatment. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection. | 07-03-2014 |
Patent application number | Description | Published |
20130059372 | SAMPLE PROCESSING UNITS, SYSTEMS, AND RELATED METHODS - Sample processing units useful for mixing and purifying materials, such as fluidic materials are provided. A sample processing unit typically includes a container configured to contain a sample comprising magnetically responsive particles, and one or more magnets that are in substantially fixed positions relative to the container. A sample processing unit also generally includes a conveyance mechanism configured to convey the container to and from a position that is within magnetic communication with the magnet, e.g., such that magnetically responsive particles with captured analytes can be retained within the container when other materials are added to and/or removed from the container. Further, a sample processing unit also typically includes a rotational mechanism that is configured to rotate the container, e.g., to effect mixing of sample materials disposed within the container. Related carrier mechanisms, sample processing stations, systems, and methods are also provided. | 03-07-2013 |
20130296996 | Transdermal Medical Patch - A medical patch having a multi-piece bottom liner including a central liner sequentially removable independently of two outer perimeter liners. The multi-piece liner covering two adhesives of different peel force. Removal of the central liner exposes a first temporary/repositionable adhesive. Once properly positioned, the outer perimeter liners are removed to expose a second stronger adhesive. A foam cushioning layer is disposed beneath and extends beyond a footprint of every printed circuit board to prevent skin irritation. The medical patch may be designed specifically for stimulation of the sacral (S3 foramen) spinal nerve without the use of a separate mechanical placement tool or assistance by another. | 11-07-2013 |
20140154043 | MICROPLATE HANDLING SYSTEMS AND RELATED COMPUTER PROGRAM PRODUCTS AND METHODS - Systems, computer program products, and methods useful for handling or managing microplates are provided. | 06-05-2014 |
20140307520 | MIXING CARTRIDGES, MIXING STATIONS, AND RELATED KITS, SYSTEMS, AND METHODS - Cartridges useful for mixing materials, such as fluidic materials are provided. A cartridge typically includes a body structure having surfaces that define a cavity with upper and lower portions. A rotatable member generally extends along a horizontal axis in the upper portion of the cavity. One or more protrusions typically extend outward from the rotatable member and into the lower portion of the cavity, and are configured to mix the material when the material is disposed in the cavity. Related mixing stations, systems, kits, and methods are also provided. | 10-16-2014 |
20150098301 | MIXING CARTRIDGES, MIXING STATIONS, AND RELATED KITS, SYSTEMS, AND METHODS - Cartridges useful for mixing materials, such as fluidic materials are provided. A cartridge typically includes a body structure having surfaces that define a cavity with upper and lower portions. A rotatable member generally extends along a horizontal axis in the upper portion of the cavity. One or more protrusions typically extend outward from the rotatable member and into the lower portion of the cavity, and are configured to mix the material when the material is disposed in the cavity. Related mixing stations, systems, kits, and methods are also provided. | 04-09-2015 |
Patent application number | Description | Published |
20140357472 | METHOD OF MAKING SUBSTANTIALLY NONPOROUS SUBSTRATE SUPPORTED NOBLE METAL- AND LANTHANIDE-CONTAINING CATALYSTS - Aspects of the invention relate to hydrogenation catalysts, and hydrogenation processes using these catalysts, having particular characteristics, in terms of the amount and type of metal hydrogenation component (or catalytic constituent), as well as the support or substrate. The catalyst compositions, comprising both a noble metal and a lanthanide element on a substantially non-porous substrate, provide advantageous performance characteristics, including conversion, selectivity, and activity stability, as demanded in industrial hydrogenation and selective hydrogenation applications. | 12-04-2014 |
20140357911 | SUBSTANTIALLY NONPOROUS SUBSTRATE SUPPORTED NOBLE METAL- AND LANTHANIDE-CONTAINING CATALYSTS FOR HYDROGENATION REACTIONS - Aspects of the invention relate to hydrogenation catalysts, and hydrogenation processes using these catalysts, having particular characteristics, in terms of the amount and type of metal hydrogenation component (or catalytic constituent), as well as the support or substrate. The catalyst compositions, comprising both a noble metal and a lanthanide element on a substantially non-porous substrate, provide advantageous performance characteristics, including conversion, selectivity, and activity stability, as demanded in industrial hydrogenation and selective hydrogenation applications. | 12-04-2014 |
Patent application number | Description | Published |
20120296129 | SUBSTANTIALLY NON-POROUS SUBSTRATE SUPPORTED NOBLE METAL-AND LANTHANIDE-CONTAINING CATALYSTS - Aspects of the invention relate to hydrogenation catalysts, and hydrogenation processes using these catalysts, having particular characteristics, in terms of the amount and type of metal hydrogenation component (or catalytic constituent), as well as the support or substrate. The catalyst compositions, comprising both a noble metal and a lanthanide element on a substantially non-porous substrate, provide advantageous performance characteristics, including conversion, selectivity, and activity stability, as demanded in industrial hydrogenation and selective hydrogenation applications. | 11-22-2012 |
20120321039 | SOLID MATERIAL CHARACTERIZATION WITH X-RAY SPECTRA IN BOTH TRANSMISSION AND FLUORESENCE MODES - Methods are disclosed utilizing synchrotron X-ray microscopy including x-ray fluorescence and x-ray absorption spectra to probe elemental distribution and elemental speciation within a material, and particularly a solid that may have one or more elements distributed on a solid substrate. Representative materials are relatively homogeneous in composition on the macroscale but relatively heterogeneous on the microscale. The analysis of such materials, particularly on a macroscale at which their heterogeneous nature can be observed, provides valuable insights into the relationships or correlations between localized concentrations of elements and/or their species, and concentrations of other components of the materials. Sample preparation methods, involving the use of a reinforcing agent, which are advantageously used in such methods are also disclosed. | 12-20-2012 |